"Probiotics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Live microbial DIETARY SUPPLEMENTS which beneficially affect the host animal by improving its intestinal microbial balance. Antibiotics and other related compounds are not included in this definition. In humans, lactobacilli are commonly used as probiotics, either as single species or in mixed culture with other bacteria. Other genera that have been used are bifidobacteria and streptococci. (J. Nutr. 1995;125:1401-12)
| Descriptor ID |
D019936
|
| MeSH Number(s) |
G07.203.300.456.500 J02.500.456.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Probiotics".
Below are MeSH descriptors whose meaning is more specific than "Probiotics".
This graph shows the total number of publications written about "Probiotics" by people in this website by year, and whether "Probiotics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Probiotics" by people in Profiles.
-
Cheng C, England E. Nutrition: Chronic Disease Management. FP Essent. 2024 Apr; 539:23-34.
-
Chisari E, Wouthuyzen-Bakker M, Friedrich AW, Parvizi J. The relation between the gut microbiome and osteoarthritis: A systematic review of literature. PLoS One. 2021; 16(12):e0261353.
-
Serce Pehlevan O, Benzer D, Gursoy T, Aktas Cetin E, Karatekin G, OvaliMD F. Cytokine responses to symbiotic and lactoferrin combination in very low birth weight neonates: a randomized control trial. Arch Argent Pediatr. 2020 02; 118(1):e8-e15.
-
Karadag AS, Kayiran MA, Parish LC. Probiotics and Prebiotics-The Good Germs: A Dermatologic Perspective. Skinmed. 2020; 18(1):10-13.
-
Gallo A, Passaro G, Gasbarrini A, Landolfi R, Montalto M. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol. 2016 Aug 28; 22(32):7186-202.
-
Vassallo G, Mirijello A, Ferrulli A, Antonelli M, Landolfi R, Gasbarrini A, Addolorato G. Review article: Alcohol and gut microbiota - the possible role of gut microbiota modulation in the treatment of alcoholic liver disease. Aliment Pharmacol Ther. 2015 May; 41(10):917-27.
-
Topcuoglu S, Gursoy T, Ovali F, Serce O, Karatekin G. A new risk factor for neonatal vancomycin-resistant Enterococcus colonisation: bacterial probiotics. J Matern Fetal Neonatal Med. 2015 Aug; 28(12):1491-4.
-
Serce O, Gursoy T, Ovali F, Karatekin G. Effects of Saccharomyces boulardii on neonatal hyperbilirubinemia: a randomized controlled trial. Am J Perinatol. 2015 Feb; 30(2):137-42.
-
Serce O, Benzer D, Gursoy T, Karatekin G, Ovali F. Efficacy of Saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: a randomised controlled trial. Early Hum Dev. 2013 Dec; 89(12):1033-6.
-
Montalto M, Gallo A, Gasbarrini A, Landolfi R. NSAID enteropathy: could probiotics prevent it? J Gastroenterol. 2013 Jun; 48(6):689-97.